Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration
- PMID: 9796893
- DOI: 10.1016/s1071-3581(98)90177-5
Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration
Abstract
Background: Reversal of ischemia after myocardial infarction by revascularization is worthwhile only if viability exists in a sufficiently large portion of the left ventricle.
Methods and results: To determine myocardial hypoperfusion reversibility and its influence on segmental and global function, we studied 50 patients after myocardial infarction. Three technetium 99m-tetrofosmin scintigraphies were performed: 1 at rest, 1 after 0.6 mg sublingual nitroglycerin (NTG), and 1 after injection at peak stress. First-pass multigated radionuclide angiography was obtained at rest and after NTG. Each patient also underwent a stress redistribution-reinjection thallium-201 scintigraphy. During stress 99mTc-tetrofosmin, 104 segments had normal uptake, 51 showed moderately reduced uptake, and 186 had severely reduced uptake. Of these 186 segments, 33 (18%) improved at rest, and 41 (22%) improved only after NTG. Fifty-nine (79%) of these segments with improved uptake were also found to have reversible defects on 201TI imaging. In the 26 patients with ventricular dysfunction, a 73% agreement was found between the functional and 99mTc-tetrofosmin uptake post-NTG improvement, whereas a 69% agreement was found with thallium reinjection. No significant differences were seen between 99mTc-tetrofosmin and 201T1 imaging.
Conclusion: Nitroglycerin administration during 99mTc-tetrofosmin scintigraphy improves the detection of myocardium with reversible hypoperfusion in patients with a previous myocardial infarction.
Comment in
-
Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used?J Nucl Cardiol. 1998 Sep-Oct;5(5):527-32. doi: 10.1016/s1071-3581(98)90184-2. J Nucl Cardiol. 1998. PMID: 9796900 No abstract available.
Similar articles
-
Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography.Eur J Nucl Med. 1997 Jul;24(7):767-73. doi: 10.1007/BF00879665. Eur J Nucl Med. 1997. PMID: 9211763
-
[Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].Rev Esp Cardiol. 1998;51 Suppl 1:45-52. Rev Esp Cardiol. 1998. PMID: 9549398 Clinical Trial. Spanish.
-
Technetium-99m-tetrofosmin imaging with incremental nitroglycerin infusion to detect severely ischaemic but viable myocardium: a comparative study with thallium-201.Nucl Med Commun. 2003 Sep;24(9):987-94. doi: 10.1097/00006231-200309000-00007. Nucl Med Commun. 2003. PMID: 12960598 Clinical Trial.
-
[Thallium scintigraphy for determining myocardial vitality. Evaluation of the "stunned and hibernating myocardium"].Herz. 1994 Feb;19(1):7-18. Herz. 1994. PMID: 8150416 Review. German.
-
Single-photon perfusion imaging for the assessment of myocardial viability.J Nucl Med. 1994 Apr;35(4 Suppl):23S-31S. J Nucl Med. 1994. PMID: 8151409 Review.
Cited by
-
Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used?J Nucl Cardiol. 1998 Sep-Oct;5(5):527-32. doi: 10.1016/s1071-3581(98)90184-2. J Nucl Cardiol. 1998. PMID: 9796900 No abstract available.
-
EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):855-97. doi: 10.1007/s00259-005-1779-y. Eur J Nucl Med Mol Imaging. 2005. PMID: 15909197
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources